• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,180.72 -104.35
( -0.13%)
Global Indices
Nasdaq
53,071.47 150.40
(0.28%)
Dow Jones
7,557.54 53.30
(0.71%)
Hang Seng
68,399.59 -1,338.10
(-1.92%)
Nikkei 225
10,649.07 -29.96
(-0.28%)
Forex
USD-INR
95.19 -0.09
(-0.09%)
EUR-INR
108.86 0.10
(0.10%)
GBP-INR
127.02 0.03
(0.03%)
JPY-INR
0.59 0.00
(-0.02%)

EQUITY - MARKET SCREENER

Gland Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
543245
INE068V01023
655.3150344
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAND
30.83
40620.5
EPS(TTM)
Face Value()
Div & Yield %
79.87
1
0.81
 

Delphi World Money reports consolidated net loss of Rs 2.08 crore in the March 2026 quarter
May 29,2026
Net loss of Delphi World Money reported to Rs 2.08 crore in the quarter ended March 2026 as against net profit of Rs 2.87 crore during the previous quarter ended March 2025. Sales rose 1370.48% to Rs 61.76 crore in the quarter ended March 2026 as against Rs 4.20 crore during the previous quarter ended March 2025.

For the full year,net profit rose 46.94% to Rs 2.88 crore in the year ended March 2026 as against Rs 1.96 crore during the previous year ended March 2025. Sales rose 602.16% to Rs 165.85 crore in the year ended March 2026 as against Rs 23.62 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales61.764.20 1370 165.8523.62 602
OPM %-5.0470.24 -2.75-2.07 -
PBDT3.476.99 -50 15.8015.73 0
PBT2.336.72 -65 11.8614.57 -19
NP-2.082.87 PL 2.881.96 47